Surgery Partners (NASDAQ:SGRY) was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a report issued on Tuesday.

Several other brokerages have also recently commented on SGRY. Jefferies Group restated a “buy” rating and issued a $16.00 target price (down from $22.00) on shares of Surgery Partners in a research report on Friday, September 8th. KeyCorp restated a “hold” rating on shares of Surgery Partners in a research report on Friday, September 22nd. Zacks Investment Research cut shares of Surgery Partners from a “hold” rating to a “strong sell” rating in a research report on Saturday, November 4th. ValuEngine cut shares of Surgery Partners from a “hold” rating to a “sell” rating in a research report on Thursday, November 9th. Finally, Bank of America cut shares of Surgery Partners from a “buy” rating to a “neutral” rating and set a $19.00 target price for the company. in a research report on Wednesday, November 1st. Four research analysts have rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the company. Surgery Partners currently has an average rating of “Hold” and a consensus target price of $18.57.

Shares of Surgery Partners (SGRY) traded up $0.45 during trading hours on Tuesday, hitting $9.75. 489,700 shares of the stock traded hands, compared to its average volume of 333,233. The firm has a market cap of $475.50 and a PE ratio of 62.00. The company has a quick ratio of 1.92, a current ratio of 2.09 and a debt-to-equity ratio of 1.56. Surgery Partners has a one year low of $7.10 and a one year high of $24.05.

Several institutional investors have recently made changes to their positions in the stock. Sterling Capital Management LLC bought a new stake in shares of Surgery Partners during the 3rd quarter valued at approximately $210,000. Bain Capital Investors LLC bought a new stake in shares of Surgery Partners during the 3rd quarter valued at approximately $273,816,000. Royce & Associates LP grew its holdings in shares of Surgery Partners by 160.0% during the 3rd quarter. Royce & Associates LP now owns 681,582 shares of the company’s stock valued at $7,054,000 after purchasing an additional 419,457 shares during the last quarter. Elk Creek Partners LLC grew its holdings in shares of Surgery Partners by 6.9% during the 3rd quarter. Elk Creek Partners LLC now owns 464,829 shares of the company’s stock valued at $4,811,000 after purchasing an additional 30,172 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Surgery Partners by 119.6% during the 3rd quarter. Dimensional Fund Advisors LP now owns 305,909 shares of the company’s stock valued at $3,166,000 after purchasing an additional 166,590 shares during the last quarter. 94.16% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This article was first published by American Banking News and is the sole property of of American Banking News. If you are reading this article on another site, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/12/12/surgery-partners-sgry-upgraded-at-bidaskclub.html.

About Surgery Partners

Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.